Mr. Howard Lin is the General Manager (Hong Kong & Macau) of Eli Lilly Asia, Inc. He has more than 22 years of experience in the pharmaceutical industry across markets in the US, Hong Kong, SE Asia, and China. As a Board member, Mr Lin is committed to assisting members of the various task forces in contributing to the best of their capabilities, serving as an ambassador of the HKAPI through engagements, and amplifying the strengths of the Hong Kong healthcare system through HKAPI-committed initiatives with the outcome of improving lives of those living in Hong Kong